NEXTBio Capital Management LP
Clone Performance
Feb 2026–Sep 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. Returns use comparable raw closes and exclude dividends. Returns are unavailable when a held security or benchmark crosses a captured split without a certified price basis; the requested window is not shortened to hide it. It tracks 100% of reported value on average across 3 quarters. Past performance does not predict future results.
Portfolio Concentration
22 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Portfolio Trend
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $217,397,093 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| STTK | Shattuck Labs, Inc. | +577,441 | 3,727,348 | $25,867,795 | |
| IVA | Inventiva S.A. | +454,500 | 1,787,984 | $6,758,579 | |
| ORIC | Oric Pharmaceuticals, Inc. | +182,505 | 706,124 | $7,647,322 | |
| GPCR | Structure Therapeutics Inc. | +179,257 | 312,496 | $16,771,660 | |
| PCVX | Vaxcyte, Inc. | +12,000 | 107,223 | $6,232,872 | |
| PVLA | Palvella Therapeutics, Inc. | +7,223 | 89,909 | $13,739,893 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | +5,680 | 131,758 | $14,629,090 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CMPS | COMPASS Pathways plc | −245,648 | 1,775,759 | $25,126,989 | |
| VOR | Vor Biopharma Inc. | −110,803 | 889,164 | $16,369,509 | |
| EVMN | Evommune, Inc. | −65,000 | 119,063 | $1,582,347 | |
| PTGX | Protagonist Therapeutics, Inc | −10,286 | 219,333 | $26,885,839 | |
| COGT | Cogent Biosciences, Inc. | −113 | 131,075 | $5,072,602 | |
| No positions match the current search. | |||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
Reduced | 219,333 | $26,885,839 | 12.37% | |
| STTK |
Shattuck Labs, Inc.
Healthcare
|
Added | 3,727,348 | $25,867,795 | 11.90% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Reduced | 1,775,759 | $25,126,989 | 11.56% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 312,496 | $16,771,660 | 7.71% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
Reduced | 889,164 | $16,369,509 | 7.53% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Added | 131,758 | $14,629,090 | 6.73% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
Added | 89,909 | $13,739,893 | 6.32% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Held | 183,225 | $11,059,461 | 5.09% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
Held | 426,736 | $10,830,559 | 4.98% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Added | 706,124 | $7,647,322 | 3.52% | |
| IVA |
Inventiva S.A.
Healthcare
|
Added | 1,787,984 | $6,758,579 | 3.11% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
Held | 372,856 | $6,711,408 | 3.09% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Added | 107,223 | $6,232,872 | 2.87% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 131,075 | $5,072,602 | 2.33% | |
| VSTM |
Verastem, Inc.
Healthcare
|
Held | 1,306,800 | $4,991,976 | 2.30% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Held | 52,655 | $3,851,186 | 1.77% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
NEW | 108,055 | $3,736,541 | 1.72% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
Held | 183,362 | $3,483,878 | 1.60% | |
| BIOA |
BioAge Labs, Inc.
Healthcare
|
NEW | 100,732 | $2,468,941 | 1.14% | |
| LBRX |
Lb Pharmaceuticals Inc
Healthcare
|
NEW | 68,249 | $2,215,021 | 1.02% | |
| EVMN |
Evommune, Inc.
Healthcare
|
Reduced | 119,063 | $1,582,347 | 0.73% | |
| ACET |
Adicet Bio, Inc.
Healthcare
|
Held | 157,827 | $1,363,625 | 0.63% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.